Marshall & Sterling Wealth Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$59.5K Buy
463
+3
+0.7% +$351 0.04% 140
2026
Q1
$55.3K Buy
460
+4
+0.9% +$462 0.04% 140
2025
Q4
$48K Sell
456
-90
-16% -$8.45K 0.03% 145
2025
Q3
$45.7K Buy
546
+5
+0.9% +$412 0.03% 181
2025
Q2
$42.8K Buy
541
+45
+9% +$3.58K 0.03% 180
2025
Q1
$44.5K Buy
496
+56
+13% +$5.23K 0.03% 168
2024
Q4
$43.7K Buy
+440
New +$45.4K 0.03% 138

Other funds holding MRK

Marshall & Sterling Wealth Advisors's MRK Position: Q2 2026 in Review

Marshall & Sterling Wealth Advisors increased its Merck (MRK) stake by 0.65% in Q2 2026, buying an estimated $351 and bringing the position to 463 shares worth $59.5K. The position accounts for 0.04% of the portfolio, ranked #140.

Marshall & Sterling Wealth Advisors first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 3,824 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Marshall & Sterling Wealth Advisors held 463 shares of Merck worth $59.5K as of Q2 2026.
  • Marshall & Sterling Wealth Advisors bought 3 Merck shares in Q2 2026, an estimated $351.
  • Merck made up 0.04% of Marshall & Sterling Wealth Advisors's portfolio in Q2 2026, its #140 holding.
  • Marshall & Sterling Wealth Advisors first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 3,824 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Marshall & Sterling Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.